Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
OptiBiotix Health ( (GB:OPTI) ) has issued an update.
OptiBiotix Health plc has launched a new prebiotic lemonade drink, FeelFull, in the United States, in collaboration with Daily Nouri. This product, containing SlimBiome®, is designed to help regulate appetite and support metabolic health, marking a significant expansion into the U.S. market. The launch represents a strategic step in OptiBiotix’s global expansion, having already established a presence in India, China, and other parts of Asia, aiming to build a substantial global business and multiple revenue streams.
More about OptiBiotix Health
OptiBiotix Health plc, founded in March 2012, is a life sciences company focused on developing compounds to modify the human microbiome. Their efforts aim to prevent and manage diseases while promoting wellness, with a particular emphasis on obesity, cardiovascular health, and diabetes. The company collaborates with international food and healthcare supplement firms to integrate their microbiome modulators into various food products and drinks.
YTD Price Performance: -15.28%
Average Trading Volume: 394,432
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: £14.94M
For an in-depth examination of OPTI stock, go to TipRanks’ Stock Analysis page.
